Insider · CIK 0001336198
Esopus Creek Value Series Fund LP - Series A
Files at SNFI (Stark Novus Financial Inc.). First filing Apr 28, 2025, latest Aug 27, 2026.
In brief
Esopus Creek Value Series Fund LP - Series A files SEC Form 4 as director at SNFI (Stark Novus Financial Inc.). Since Apr 28, 2025, Esopus Creek Value Series Fund LP - Series A has reported 4 open-market buys worth $106k and 0 open-market sells worth $0, the latest filed on Aug 27, 2026.
After Esopus Creek Value Series Fund LP - Series A's past buys, the stock beat the S&P 500 by a median 41.7% over six months (n = 3), and 100% of those buys were ahead of the index at six months. InsiderTell labels that a strong record.
The newest scored trade: bought $16k of SNFI on Aug 25, 2026, filed Aug 27, 2026, scored 41 (moderate). In the last 12 months: 3 buys worth $86k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SNFI: Stark Novus Financial Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 41Moderate | Stark Novus Financial Inc. | $16k 9,000 shares | +1% | +34% from low-32% from high | |
| 30Weak | SNFIbuy Stark Novus Financial Inc. | $58k 40,000 shares | +6% | - | |
| 30Weak | Stark Novus Financial Inc. | $12k 8,000 shares | +1% | - | |
| 23Weak | Stark Novus Financial Inc. | $20k 15,000 shares | +2% | - |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 25, 2026 | SNFI Stark Novus Financial Inc. | POpen-market purchase Common Stock, par value $0.0001 | +9,000 | $1.83 | $16k | 772,000 | Aug 27, 2026 |
| Dec 16, 2025 | SNFI Stark Novus Financial Inc. | POpen-market purchase Common Stock, par value $0.0001 | +16,787 | $1.41 | $24k | 739,787 | Dec 18, 2025 |
| Dec 17, 2025 | SNFI Stark Novus Financial Inc. | POpen-market purchase Common Stock, par value $0.0001 | +23,213 | $1.48 | $34k | 763,000 | Dec 18, 2025 |
| Nov 19, 2025 | SNFI Stark Novus Financial Inc. | POpen-market purchase Common Stock, par value $0.0001 | +8,000 | $1.45 | $12k | 723,000 | Nov 21, 2025 |
| Apr 24, 2025 | SNFI Stark Novus Financial Inc. | POpen-market purchase Common Stock, par value $0.0001 | +7,500 | $1.32 | $9,900 | 707,500 | Apr 28, 2025 |
| Apr 25, 2025 | SNFI Stark Novus Financial Inc. | POpen-market purchase Common Stock, par value $0.0001 | +7,500 | $1.32 | $9,937 | 715,000 | Apr 28, 2025 |
Questions about Esopus Creek Value Series Fund LP - Series A
Answered from the filings on this page, as of the latest one.
Is Esopus Creek Value Series Fund LP - Series A buying or selling?
In the last 12 months Esopus Creek Value Series Fund LP - Series A reported 3 open-market buys worth $86k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $16k of SNFI on Aug 25, 2026. Grants, option exercises and tax withholding are not counted.
How did Esopus Creek Value Series Fund LP - Series A's past buys perform?
Measured from the first close after each filing, the stock beat the S&P 500 by a median 41.7% over six months across 3 past buys, with 100% ahead of the index. Past results describe what happened; they do not predict the next trade.
Where does Esopus Creek Value Series Fund LP - Series A file Form 4?
Esopus Creek Value Series Fund LP - Series A has filed Form 4 at SNFI (Stark Novus Financial Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.